Applicant, as named in the Orange Book

Jazz

Next listed expiry: Zepzelca on 13 Dec 2029. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Zepzelca lurbinectedin	lurbinectedin	213702	13 Dec 2029	patent
Xywav calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate	calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate	212690	22 Feb 2041	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.